CTRI/2021/01/030807已完成2 期
Pre-operative use of Febuxostat in cardiac surgery- a double blind prospective ramdomized phase II trial
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- AIIMS
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •As per parameters defined above all adult patients undergoing cardiac surgery under with overall EUROSCORE II < 20%
- •Specific parameters: -
- •- Age 18- 65
- •- Elective and Urgent procedure
- •- Weight of procedure –
- •1.Isolated CABG
- •2.Isolated non-CABG major procedure (e.g. single valve procedure, replacement of ascending aorta, correction of septal defect, etc)
- •3.2 major procedures (e.g. CABG and AVR), or CABG and mitral valve repair (MVR), or AVR and replacement of ascending aorta, or CABG and maze procedure, or AVR and MVR, etc
排除标准
- •1Cyanotic heart disease
- •2Off pump procedure, DHCA
- •3Emergency and salvage procedures
- •4=3 major procedures (e.g. AVR, MVR, and CABG, or MVR, CABG, and tricuspid annuloplasty, etc), or aortic root replacement when it includes AVR or repair, coronary reimplantation, and root and ascending replacement
- •5Severe renal dysfunction
- •- =50 mL/min
- •- On dialysis (regardless of serum creatinine)
- •6NYHA Class IV: symptoms at rest
- •7Poor (LVEF 21-30%), Very poor (LVEF =20%)
- •8Active infection
研究者
相似试验
进行中（未招募）
不适用
Prophylaxis with fenoldopam in cardiac surgery patients at high risk of postoperative renal failure - NDcardiac surgery patients at high risk of postoperative renal failureMedDRA version: 9.1Level: HLGTClassification code 10007593Term: Cardiac therapeutic proceduresEUCTR2006-003053-24-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI160
Unknown
4 期
Esmolol for Myocardial Protection in Hypertrophic Obstructive CardiomyopathyHypertrophic Obstructive CardiomyopathyNCT05073094Meshalkin Research Institute of Pathology of Circulation80
招募中
不适用
Fluvastatin and bisoprolol for the reduction of perioperative cardiac mortality and morbidity in high-risk patients undergoing non-cardiac surgery.non-cardiac surgerybeta-blockerstatinperioperative cardiac complicationsNL-OMON21523Department of Anesthesiology, Erasmus MC Rotterdam, the Netherlands6,000
进行中（未招募）
不适用
Sevoflurane on cardiac surgery: vantage to use during CECgeneral anestetic inalathory also during CECMedDRA version: 6.1Level: PTClassification code 10018060EUCTR2005-001574-27-ITAZIENDA OSPEDALIERA DI PERUGIA
已完成
4 期
Volatile Anesthetics in Cardiac ProtectionAnesthesiaNCT00364637Università Vita-Salute San Raffaele